.Amgen has shared (PDF) the initial stage 3 information on its $400 million dermatitis medicine, con...
.Biogen as well as UCB's bank on advancing into phase 3 astride a failed study tries to have repaid,...
.Italian biotech Aptadir Therapies has launched with the pledge that its pipe of preclinical RNA pre...
.Surge Life Sciences has fulfilled its own goal in a Duchenne muscle dystrophy (DMD) research study,...
.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fold, taki...
.Achilles Rehabs has wrecked its own tactic. The English biotech is actually stopping work on its cl...
.Aligos Therapies is actually proclaiming a midstage succeed in metabolic-dysfunction associated ste...
.Basilea Pharmaceutica's work creating new antifungals has actually received a significant increase ...
.Having actually gathered up the USA legal rights to Capricor Therapies' late-stage Duchenne muscula...
.After dismissing the selection meeting for Applied Therapeutics' metabolic problem medicine govores...